VRIZIDE MV 80.2 TABLET
Generic Salt Composition: Gliclazide 80mg + Metformin 500mg SR + Voglibose 0.2mg
Price: ₹54 MRP: ₹138.94
Save up to 61% compared to branded medicines.
Top Brand Substitutes & Equivalents
Glyciphage-VG, Voglinorm-GM, Glicomet-VG, Gluconorm-VG, Volix-GM, Glimisave-MV, Diabetrol-MV, Vogli-GM, Gliclazide-Metformin-Voglibose combination, Met-Vog-Glic, Zoryl-MV, Glic-Met-Vog, Voglibose-Gliclazide-Metformin, Gliclazide-MV, Met-Glic-Vog, Glycomet 500 SR, Glycomet 850, Glycomet 1000 SR, Cetapin 500, Cetapin 1000, Glucophage 500, Glucophage XR 1000, Obimet 500, Obimet 1000, Formin 500, Exermet 500, Metfor 500, Glycomet GP 1, Glycomet GP 2, Gluconorm-G 1
Product Overview & Uses
VRIZIDE MV 80.2 TABLET is a comprehensive therapeutic solution for patients struggling with glycemic control in Type 2 Diabetes Mellitus. Classified under the Diabetes Care category, this medication is designed to address multiple pathways of hyperglycemia. Gliclazide stimulates insulin secretion from pancreatic beta cells, Metformin reduces hepatic glucose production and improves peripheral insulin sensitivity, and Voglibose delays the intestinal absorption of carbohydrates by inhibiting alpha-glucosidase enzymes. By combining these three distinct mechanisms, VRIZIDE MV 80.2 TABLET provides a robust approach to lowering both fasting and postprandial blood glucose levels. It is typically prescribed when diet, exercise, and single-agent therapy fail to achieve target HbA1c levels. Patients using this medication should be monitored regularly for blood glucose fluctuations and potential gastrointestinal side effects common with metformin-based therapies.